跳至主要内容
临床试验/CTRI/2025/04/083834
CTRI/2025/04/083834尚未招募不适用

A randomized control clinical study on the effect of Madhutailik Basti with oral hypoglycemic agents on HbA1c value in Prameha with special reference to type 2 diabetes mellitus.

Sane Guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月5日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
To study the effect of Madhutailik Basti with Oral hypoglycemic agents on

研究概览

简要总结

This is a comparative clinical study of add on effect of Madhutailik Basti on HbA1c value in prameha (type 2 diabetes mellitus)  with oral hypoglycemic agents. The primary objective is to study the effect of Madhutailik Basti with oral hypoglycemic agents on HbA1c value if given for 7 days in consecutive 3 months. one group of prameha (type 2 dibetes mellitus) patients will be treated with oral hypoglycemic agents. second group of prameha (type 2 diabetes mellitus) patients will be treated with Madhutailik Basti along with oral hypoglycemic agents to study the add on effect .

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed patients of Type 2 Diabetes Mellitus.
  • HbA1c value 6.5% or above.
  • Age group between 30 to 60 years.
  • Patients taking anti-diabetic drugs.
  • Fasting blood sugar level within 150 mg/dl and Post prandial blood sugar within 250 mg/dl.
  • Patient who is taking regular OHA(Oral Hypoglycemic agents) upto three molecules Basti Arha18.

排除标准

  • Patients of insulin dependent diabetes mellitus (Type I).
  • Diabetes due to Endocrinopathies for eg.
  • Acromegaly, Cushing syndrome.
  • Drugs or chemical induced diabetes mellitus.
  • Hypertension Patients with other systemic complication which may interfere in treatment.
  • Pregnant and lactating women.

结局指标

主要结局

To study the effect of Madhutailik Basti with Oral hypoglycemic agents on

时间窗: Patients will be assessed on 0th, 7th, 37th, 67th day and follow up on 90th day.

HbA1c value.

时间窗: Patients will be assessed on 0th, 7th, 37th, 67th day and follow up on 90th day.

次要结局

  • To study the effect of Madhutailik Basti with Oral hypoglycemic agents on(blood glucose level.)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Nilima Anandrao Patekar

Sumatibhai shah Ayurveda Mahavidyalaya,Malwadi,Hadapsar,Pune

研究点 (1)

Loading locations...

相似试验

A clinical study of effect of Madhutailik... | 临床试验